GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Pharmalabs Ltd (BOM:543748) » Definitions » Total Inventories

Aarti Pharmalabs (BOM:543748) Total Inventories : ₹0 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Aarti Pharmalabs Total Inventories?

Aarti Pharmalabs's total inventories for the quarter that ended in Dec. 2024 was ₹0 Mil. Aarti Pharmalabs's average total inventories from the quarter that ended in Sep. 2024 to the quarter that ended in Dec. 2024 was ₹3,599 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Aarti Pharmalabs's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was ₹N/A.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Aarti Pharmalabs's Days Inventory for the three months ended in Dec. 2024 was 119.29.

Inventory Turnover measures how fast the company turns over its inventory within a year. Aarti Pharmalabs's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.76.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Aarti Pharmalabs's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.67.


Aarti Pharmalabs Total Inventories Historical Data

The historical data trend for Aarti Pharmalabs's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Pharmalabs Total Inventories Chart

Aarti Pharmalabs Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Total Inventories
- 4,754.54 6,020.41 6,428.58

Aarti Pharmalabs Quarterly Data
Mar21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 6,428.58 - 7,197.96 -

Aarti Pharmalabs Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Aarti Pharmalabs  (BOM:543748) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Aarti Pharmalabs's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is

Net-Net Working Capital Per Share (Q: Dec. 2024 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0+0.75 * 0+0.5 * 0-N/A
-0-0)/90.626
=N/A

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Aarti Pharmalabs's Days Inventory for the three months ended in Dec. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2024 )/Cost of Goods Sold (Q: Dec. 2024 )*Days in Period
=3598.98/2753.078*365 / 4
=119.29

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Aarti Pharmalabs's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2024 ) / Average Total Inventories (Q: Dec. 2024 )
=2753.078 / 3598.98
=0.76

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Aarti Pharmalabs's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=3598.98 / 5377.782
=0.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Aarti Pharmalabs Total Inventories Related Terms

Thank you for viewing the detailed overview of Aarti Pharmalabs's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarti Pharmalabs Business Description

Traded in Other Exchanges
Address
Mulund Goregaon Link Road, 2nd floor, 204, Udyog Kshetra, Mulund West, Mumbai, MH, IND, 400080
Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. It manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, and xanthine derivatives in India. It also offers Contract Development and Manufacturing Services (CDMS) for drug substance (NCE, RSM, Intermediates) projects. Geographically, the company generates maximum revenue from its customers located outside India.

Aarti Pharmalabs Headlines

No Headlines